Axsome Therapeutics Stock Is Up 16% Year to Date. Why Wall Street Thinks It Has Even More Room to Run
Axsome Therapeutics (NASDAQ: AXSM), a biotech company, has performed fairly well this year. The company’s...
Axsome Therapeutics (NASDAQ: AXSM), a biotech company, has performed fairly well this year. The company’s...
Grace, 14, feels doctors were dismissive of her pain. She wants others to know the symptoms.
Hayley Metcalfe, 37, suffered the loss of two babies at 17 and 19 weeks into the pregnancies.
Nearly 600 practices in England have withdrawn from NHS dentistry over the last 10 years, as the service heads towards a two-tier system.
Yet again, England are dealing with a player involved in a late-night incident. Only strong action will ensure there are no more, writes Stephan Shemilt.
If you fancy yourself a fan of gold or silver, you’re feeling a bit more...
Canadian Prime Minister Mark Carney drew international attention earlier this year by warning that middle powers such as Canada must resist economic coercion.
Flock operates in more than 5,000 communities across 49 states, and is an $8.3 billion venture darling. Now, the company’s run into trouble.
The huge increase in interest expense has two sources.